The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma
Open accessAbstract
Phenotypic plasticity has emerged as a major contributor to intra-tumoral heterogeneity and treatment resistance in cancer. Increasing evidence shows that glioblastoma (GBM) cells display prominent intrinsic plasticity and reversibly adapt to dynamic microenvironmental conditions. Limited genetic evolution at recurrence further suggests that resistance mechanisms also largely operate at the phenotypic level. Here we review recent literature underpinning the role of GBM plasticity in creating gradients of heterogeneous cells including those that carry cancer stem cell (CSC) properties. A historical perspective from the hierarchical to the nonhierarchical concept of CSCs towards the recent appreciation of GBM plasticity is provided. Cellular states interact dynamically with each other and with the surrounding brain to shape a flexible tumor ecosystem, which enables swift adaptation to external pressure including treatment. We present the key components regulating intra-tumoral phenotypic heterogeneity and the equilibrium of phenotypic states, including genetic, epigenetic, and microenvironmental factors. We further discuss plasticity in the context of intrinsic tumor resistance, where a variable balance between preexisting resistant cells and adaptive persisters leads to reversible adaptation upon treatment. Innovative efforts targeting regulators of plasticity and mechanisms of state transitions towards treatment-resistant states are needed to restrict the adaptive capacities of GBM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273 · cited 1×
“Treatment-related phenotypic changes can generally be attributed to two scenarios: (1) increased proliferation and selection of preexisting resistant cellular states over time or (2) adaptation of tumor cells towards resistant phenotypes (Figure 3).”
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Scenic: single-cell regulatory network inference and clustering.
Aibar, S., González-Blas, C. B., Moerman, T., Huynh-Thu, V. A., Imrichova, H., Hulselmans, G., Rambow, F., Marine, J.-C., Geurts, P., Aerts, J., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4463 · Cited by 6,520
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
DNA methylation-based classification of central nervous system tumours
Capper, D., Jones, D. T. W., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D., Koelsche, C., Sahm, F., Chavez, L., Reuss, D. E., et al. (2018) · Nature · doi:10.1038/nature26000 · Cited by 3,033
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Neftel, C., Laffy, J., Filbin, M. G., Hara, T., Shore, M. E., Rahme, G. J., Richman, A. R., Silverbush, D., Shaw, M. L., Hebert, C. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.024 · Cited by 2,873
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
A restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,189
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Weller, M., van den Bent, M., Preusser, M., Le Rhun, E., Tonn, J. C., Minniti, G., Bendszus, M., Balana, C., Chinot, O., Dirven, L., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00447-z · Cited by 2,048
Wang, Q., Hu, B., Hu, X., Kim, H., Squatrito, M., Scarpace, L., deCarvalho, A. C., Lyu, S., Li, P., Li, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.003 · Cited by 1,995
The Microenvironmental Landscape of Brain Tumors
Quail, D. F., & Joyce, J. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.009 · Cited by 1,862
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,790
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
Cancer stem cells in glioblastoma
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. L., & Rich, J. N. (2015) · Genes & Development · doi:10.1101/gad.261982.115 · Cited by 1,520
Electrical and synaptic integration of glioma into neural circuits
Venkatesh, H. S., Morishita, W., Geraghty, A. C., Silverbush, D., Gillespie, S. M., Arzt, M., Tam, L. T., Espenel, C., Ponnuswami, A., Ni, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1563-y · Cited by 1,366
Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma
Tirosh, I., Venteicher, A. S., Hebert, C., Escalante, L. E., Patel, A. P., Yizhak, K., Fisher, J. M., Rodman, C., Mount, C., Filbin, M. G., et al. (2016) · Nature · doi:10.1038/nature20123 · Cited by 1,234
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Venkataramani, V., Tanev, D. I., Strahle, C., Studier-Fischer, A., Fankhauser, L., Kessler, T., Körber, C., Kardorff, M., Ratliff, M., Xie, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1564-x · Cited by 1,197
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Cancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171
Jacob, F., Salinas, R. D., Zhang, D. Y., Nguyen, P. T. T., Schnoll, J. G., Wong, S. Z. H., Thokala, R., Sheikh, S., Saxena, D., Prokop, S., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.036 · Cited by 1,149
Brain tumour cells interconnect to a functional and resistant network
Osswald, M., Jung, E., Sahm, F., Solecki, G., Venkataramani, V., Blaes, J., Weil, S., Horstmann, H., Wiestler, B., Syed, M., et al. (2015) · Nature · doi:10.1038/nature16071 · Cited by 1,143
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Bhat, K. P. L., Balasubramaniyan, V., Vaillant, B., Ezhilarasan, R., Hummelink, K., Hollingsworth, F., Wani, K., Heathcock, L., James, J. D., Goodman, L. D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.001 · Cited by 1,102
Klemm, F., Maas, R. R., Bowman, R. L., Kornete, M., Soukup, K., Nassiri, S., Brouland, J.-P., Iacobuzio-Donahue, C. A., Brennan, C., Tabar, V., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.007 · Cited by 1,037
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Marusyk, A., Janiszewska, M., & Polyak, K. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.007 · Cited by 1,009
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
Venteicher, A. S., Tirosh, I., Hebert, C., Yizhak, K., Neftel, C., Filbin, M. G., Hovestadt, V., Escalante, L. E., Shaw, M. L., Rodman, C., et al. (2017) · Science · doi:10.1126/science.aai8478 · Cited by 1,004
Darmanis, S., Sloan, S. A., Croote, D., Mignardi, M., Chernikova, S., Samghababi, P., Zhang, Y., Neff, N., Kowarsky, M., Caneda, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.030 · Cited by 997
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Suvà, M. L., Rheinbay, E., Gillespie, S. M., Patel, A. P., Wakimoto, H., Rabkin, S. D., Riggi, N., Chi, A. S., Cahill, D. P., Nahed, B. V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.030 · Cited by 944
Chaffer, C. L., Marjanovic, N. D., Lee, T., Bell, G., Kleer, C. G., Reinhardt, F., D’Alessio, A. C., Young, R. A., & Weinberg, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.06.005 · Cited by 876
Heddleston, J. M., Li, Z., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9701 · Cited by 813
Bleau, A.-M., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C. W., & Holland, E. C. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.01.007 · Cited by 808
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Rambow, F., Rogiers, A., Marin-Bejar, O., Aibar, S., Femel, J., Dewaele, M., Karras, P., Brown, D., Chang, Y. H., Debiec-Rychter, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.025 · Cited by 771
Pombo Antunes, A. R., Scheyltjens, I., Lodi, F., Messiaen, J., Antoranz, A., Duerinck, J., Kancheva, D., Martens, L., De Vlaminck, K., Van Hove, H., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00789-y · Cited by 704
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
Filbin, M. G., Tirosh, I., Hovestadt, V., Shaw, M. L., Escalante, L. E., Mathewson, N. D., Neftel, C., Frank, N., Pelton, K., Hebert, C. M., et al. (2018) · Science · doi:10.1126/science.aao4750 · Cited by 696
Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
Nathanson, D. A., Gini, B., Mottahedeh, J., Visnyei, K., Koga, T., Gomez, G., Eskin, A., Hwang, K., Wang, J., Masui, K., et al. (2014) · Science · doi:10.1126/science.1241328 · Cited by 695
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Son, M. J., Woolard, K., Nam, D.-H., Lee, J., & Fine, H. A. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.003 · Cited by 672
Notch Promotes Radioresistance of Glioma Stem Cells
Wang, J., Wakeman, T. P., Lathia, J. D., Hjelmeland, A. B., Wang, X.-F., White, R. R., Rich, J. N., & Sullenger, B. A. (2010) · Stem Cells · doi:10.1002/stem.261 · Cited by 656
Resolving genetic heterogeneity in cancer
Turajlic, S., Sottoriva, A., Graham, T., & Swanton, C. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0114-6 · Cited by 653
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Gupta, P. B., Pastushenko, I., Skibinski, A., Blanpain, C., & Kuperwasser, C. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.011 · Cited by 598
Hara, T., Chanoch-Myers, R., Mathewson, N. D., Myskiw, C., Atta, L., Bussema, L., Eichhorn, S. W., Greenwald, A. C., Kinker, G. S., Rodman, C., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.05.002 · Cited by 593
Anido, J., Sáez-Borderías, A., Gonzàlez-Juncà, A., Rodón, L., Folch, G., Carmona, M. A., Prieto-Sánchez, R. M., Barba, I., Martínez-Sáez, E., Prudkin, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.023 · Cited by 572
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
Couturier, C. P., Ayyadhury, S., Le, P. U., Nadaf, J., Monlong, J., Riva, G., Allache, R., Baig, S., Yan, X., Bourgey, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17186-5 · Cited by 569
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
Wang, J., Sakariassen, P. Ø., Tsinkalovsky, O., Immervoll, H., Bøe, S. O., Svendsen, A., Prestegarden, L., Røsland, G., Thorsen, F., Stuhr, L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23130 · Cited by 567
Longitudinal molecular trajectories of diffuse glioma in adults
Barthel, F. P., Johnson, K. C., Varn, F. S., Moskalik, A. D., Tanner, G., Kocakavuk, E., Anderson, K. J., Abiola, O., Aldape, K., Alfaro, K. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1775-1 · Cited by 561
Self-citationCancer stem cell–immune cell crosstalk in tumour progression
Bayik, D., & Lathia, J. D. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00366-w · Cited by 561
Charles, N., Ozawa, T., Squatrito, M., Bleau, A.-M., Brennan, C. W., Hambardzumyan, D., & Holland, E. C. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.01.001 · Cited by 550
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Chen, R., Nishimura, M. C., Bumbaca, S. M., Kharbanda, S., Forrest, W. F., Kasman, I. M., Greve, J. M., Soriano, R. H., Gilmour, L. L., Rivers, C. S., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.049 · Cited by 544
Inda, M.-D.-M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D. W. Y., Vandenberg, S., Brennan, C., Johns, T. G., Bachoo, R., Hadwiger, P., et al. (2010) · Genes & Development · doi:10.1101/gad.1890510 · Cited by 543
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Liau, B. B., Sievers, C., Donohue, L. K., Gillespie, S. M., Flavahan, W. A., Miller, T. E., Venteicher, A. S., Hebert, C. H., Carey, C. D., Rodig, S. J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2016.11.003 · Cited by 535
Dirkse, A., Golebiewska, A., Buder, T., Nazarov, P. V., Muller, A., Poovathingal, S., Brons, N. H. C., Leite, S., Sauvageot, N., Sarkisjan, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09853-z · Cited by 529
Self-citationPeñuelas, S., Anido, J., Prieto-Sánchez, R. M., Folch, G., Barba, I., Cuartas, I., García-Dorado, D., Poca, M. A., Sahuquillo, J., Baselga, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.011 · Cited by 526
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Saygin, C., Matei, D., Majeti, R., Reizes, O., & Lathia, J. D. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.017 · Cited by 517
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
Flavahan, W. A., Wu, Q., Hitomi, M., Rahim, N., Kim, Y., Sloan, A. E., Weil, R. J., Nakano, I., Sarkaria, J. N., Stringer, B. W., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3510 · Cited by 510
Cycling cancer persister cells arise from lineages with distinct programs
Oren, Y., Tsabar, M., Cuoco, M. S., Amir-Zilberstein, L., Cabanos, H. F., Hütter, J.-C., Hu, B., Thakore, P. I., Tabaka, M., Fulco, C. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03796-6 · Cited by 502
Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma
Bhaduri, A., Di Lullo, E., Jung, D., Müller, S., Crouch, E. E., Espinosa, C. S., Ozawa, T., Alvarado, B., Spatazza, J., Cadwell, C. R., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2019.11.015 · Cited by 419
IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS
Ogden, A. T., Waziri, A. E., Lochhead, R. A., Fusco, D., Lopez, K., Ellis, J. A., Kang, J., Assanah, M., McKhann, G. M., Sisti, M. B., et al. (2008) · Neurosurgery · doi:10.1227/01.neu.0000316019.28421.95 · Cited by 408
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Lan, X., Jörg, D. J., Cavalli, F. M. G., Richards, L. M., Nguyen, L. V., Vanner, R. J., Guilhamon, P., Lee, L., Kushida, M. M., Pellacani, D., et al. (2017) · Nature · doi:10.1038/nature23666 · Cited by 405
Acidic stress promotes a glioma stem cell phenotype
Hjelmeland, A. B., Wu, Q., Heddleston, J. M., Choudhary, G. S., MacSwords, J., Lathia, J. D., McLendon, R., Lindner, D., Sloan, A., & Rich, J. N. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.150 · Cited by 402
Glioblastoma Stem Cells: Driving Resilience through Chaos
Prager, B. C., Bhargava, S., Mahadev, V., Hubert, C. G., & Rich, J. N. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.009 · Cited by 401
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
Jin, X., Kim, L. J. Y., Wu, Q., Wallace, L. C., Prager, B. C., Sanvoranart, T., Gimple, R. C., Wang, X., Mack, S. C., Miller, T. E., et al. (2017) · Nature Medicine · doi:10.1038/nm.4415 · Cited by 383
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Meyer, M., Reimand, J., Lan, X., Head, R., Zhu, X., Kushida, M., Bayani, J., Pressey, J. C., Lionel, A. C., Clarke, I. D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320611111 · Cited by 382
Bar, E. E., Lin, A., Mahairaki, V., Matsui, W., & Eberhart, C. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091021 · Cited by 373
Stewart, C. A., Gay, C. M., Xi, Y., Sivajothi, S., Sivakamasundari, V., Fujimoto, J., Bolisetty, M., Hartsfield, P. M., Balasubramaniyan, V., Chalishazar, M. D., et al. (2020) · Nature Cancer · doi:10.1038/s43018-019-0020-z · Cited by 366
Garofano, L., Migliozzi, S., Oh, Y. T., D’Angelo, F., Najac, R. D., Ko, A., Frangaj, B., Caruso, F. P., Yu, K., Yuan, J., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00159-4 · Cited by 364
The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation
Wang, L., Babikir, H., Müller, S., Yagnik, G., Shamardani, K., Catalan, F., Kohanbash, G., Alvarado, B., Di Lullo, E., Kriegstein, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0329 · Cited by 363
Auffinger, B., Tobias, A. L., Han, Y., Lee, G., Guo, D., Dey, M., Lesniak, M. S., & Ahmed, A. U. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.31 · Cited by 349
Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity
Wainwright, E. N., & Scaffidi, P. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.004 · Cited by 342
Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
Golebiewska, A., Brons, N. H. C., Bjerkvig, R., & Niclou, S. P. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.007 · Cited by 333
Self-citationExtrachromosomal oncogene amplification in tumour pathogenesis and evolution
Verhaak, R. G. W., Bafna, V., & Mischel, P. S. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0128-6 · Cited by 329
Pavlyukov, M. S., Yu, H., Bastola, S., Minata, M., Shender, V. O., Lee, Y., Zhang, S., Wang, J., Komarova, S., Wang, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.012 · Cited by 320
Akkari, L., Bowman, R. L., Tessier, J., Klemm, F., Handgraaf, S. M., de Groot, M., Quail, D. F., Tillard, L., Gadiot, J., Huse, J. T., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw7843 · Cited by 320
deCarvalho, A. C., Kim, H., Poisson, L. M., Winn, M. E., Mueller, C., Cherba, D., Koeman, J., Seth, S., Protopopov, A., Felicella, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0105-0 · Cited by 318
Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas
Weil, S., Osswald, M., Solecki, G., Grosch, J., Jung, E., Lemke, D., Ratliff, M., Hänggi, D., Wick, W., & Winkler, F. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox070 · Cited by 317
Spatiotemporal Evolution of the Primary Glioblastoma Genome
Kim, J., Lee, I.-H., Cho, H. J., Park, C.-K., Jung, Y.-S., Kim, Y., Nam, S. H., Kim, B. S., Johnson, M. D., Kong, D.-S., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.013 · Cited by 314
Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
Beier, D., Schulz, J. B., & Beier, C. P. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-128 · Cited by 312
Richards, L. M., Whitley, O. K. N., MacLeod, G., Cavalli, F. M. G., Coutinho, F. J., Jaramillo, J. E., Svergun, N., Riverin, M., Croucher, D. C., Kushida, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00154-9 · Cited by 308
Persistent Cancer Cells: The Deadly Survivors
Shen, S., Vagner, S., & Robert, C. (2020) · Cell · doi:10.1016/j.cell.2020.10.027 · Cited by 304
Wang, X., Prager, B. C., Wu, Q., Kim, L. J. Y., Gimple, R. C., Shi, Y., Yang, K., Morton, A. R., Zhou, W., Zhu, Z., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.03.011 · Cited by 285
Rheinbay, E., Suvà, M. L., Gillespie, S. M., Wakimoto, H., Patel, A. P., Shahid, M., Oksuz, O., Rabkin, S. D., Martuza, R. L., Rivera, M. N., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.021 · Cited by 276
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
Li, Y., Li, A., Glas, M., Lal, B., Ying, M., Sang, Y., Xia, S., Trageser, D., Guerrero-Cázares, H., Eberhart, C. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016912108 · Cited by 266
Johnson, K. C., Anderson, K. J., Courtois, E. T., Gujar, A. D., Barthel, F. P., Varn, F. S., Luo, D., Seignon, M., Yi, E., Kim, H., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00926-8 · Cited by 265
Körber, V., Yang, J., Barah, P., Wu, Y., Stichel, D., Gu, Z., Fletcher, M. N. C., Jones, D., Hentschel, B., Lamszus, K., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.007 · Cited by 260
Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states
Chaligne, R., Gaiti, F., Silverbush, D., Schiffman, J. S., Weisman, H. R., Kluegel, L., Gritsch, S., Deochand, S. D., Gonzalez Castro, L. N., Richman, A. R., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00927-7 · Cited by 258
CD133 Is Essential for Glioblastoma Stem Cell Maintenance
Brescia, P., Ortensi, B., Fornasari, L., Levi, D., Broggi, G., & Pelicci, G. (2013) · Stem Cells · doi:10.1002/stem.1317 · Cited by 254
Segerman, A., Niklasson, M., Haglund, C., Bergström, T., Jarvius, M., Xie, Y., Westermark, A., Sönmez, D., Hermansson, A., Kastemar, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.056 · Cited by 249
CD133 Is a Marker of Bioenergetic Stress in Human Glioma
Griguer, C. E., Oliva, C. R., Gobin, E., Marcorelles, P., Benos, D. J., Lancaster, J. R., & Gillespie, G. Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003655 · Cited by 247
Vaubel, R. A., Tian, S., Remonde, D., Schroeder, M. A., Mladek, A. C., Kitange, G. J., Caron, A., Kollmeyer, T. M., Grove, R., Peng, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0909 · Cited by 227
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
Ye, C., Ho, D. J., Neri, M., Yang, C., Kulkarni, T., Randhawa, R., Henault, M., Mostacci, N., Farmer, P., Renner, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06500-x · Cited by 222
Towards Multidrug Adaptive Therapy
West, J., You, L., Zhang, J., Gatenby, R. A., Brown, J. S., Newton, P. K., & Anderson, A. R. A. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2669 · Cited by 221
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation
Minata, M., Audia, A., Shi, J., Lu, S., Bernstock, J., Pavlyukov, M. S., Das, A., Kim, S.-H., Shin, Y. J., Lee, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.076 · Cited by 220
Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes?
Li, Y., & Laterra, J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3070 · Cited by 219
Park, N. I., Guilhamon, P., Desai, K., McAdam, R. F., Langille, E., O’Connor, M., Lan, X., Whetstone, H., Coutinho, F. J., Vanner, R. J., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.06.004 · Cited by 213
Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches
Saraon, P., Pathmanathan, S., Snider, J., Lyakisheva, A., Wong, V., & Stagljar, I. (2021) · Oncogene · doi:10.1038/s41388-021-01841-2 · Cited by 205
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
Miller, T. E., Liau, B. B., Wallace, L. C., Morton, A. R., Xie, Q., Dixit, D., Factor, D. C., Kim, L. J. Y., Morrow, J. J., Wu, Q., et al. (2017) · Nature · doi:10.1038/nature23000 · Cited by 200
PDXNET Consortium, Woo, X. Y., EurOPDX Consortium, Giordano, J., Srivastava, A., Zhao, Z.-M., Lloyd, M. W., de Bruijn, R., Suh, Y.-S., Patidar, R., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00750-6 · Cited by 190
DNA repair mechanisms and their clinical impact in glioblastoma
Erasimus, H., Gobin, M., Niclou, S., & Van Dyck, E. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.05.005 · Cited by 188
Self-citationThe Rational Development of CD133-Targeting Immunotherapies for Glioblastoma
Vora, P., Venugopal, C., Salim, S. K., Tatari, N., Bakhshinyan, D., Singh, M., Seyfrid, M., Upreti, D., Rentas, S., Wong, N., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.04.008 · Cited by 188
Dahan, P., Martinez Gala, J., Delmas, C., Monferran, S., Malric, L., Zentkowski, D., Lubrano, V, Toulas, C., Cohen-Jonathan Moyal, E., & Lemarie, A. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.509 · Cited by 187
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy
Bastola, S., Pavlyukov, M. S., Yamashita, D., Ghosh, S., Cho, H., Kagaya, N., Zhang, Z., Minata, M., Lee, Y., Sadahiro, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18189-y · Cited by 184
The GLASS Consortium, Aldape, K., Amin, S. B., Ashley, D. M., Barnholtz-Sloan, J. S., Bates, A. J., Beroukhim, R., Bock, C., Brat, D. J., Claus, E. B., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy020 · Cited by 180
Self-citationJoseph, J. V., Conroy, S., Tomar, T., Eggens-Meijer, E., Bhat, K., Copray, S., Walenkamp, A. M. E., Boddeke, E., Balasubramanyian, V, Wagemakers, M., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.395 · Cited by 178
de Souza, C. F., Sabedot, T. S., Malta, T. M., Stetson, L., Morozova, O., Sokolov, A., Laird, P. W., Wiznerowicz, M., Iavarone, A., Snyder, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.107 · Cited by 177
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
Risom, T., Langer, E. M., Chapman, M. P., Rantala, J., Fields, A. J., Boniface, C., Alvarez, M. J., Kendsersky, N. D., Pelz, C. R., Johnson-Camacho, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05729-w · Cited by 174
Brown, D. V., Filiz, G., Daniel, P. M., Hollande, F., Dworkin, S., Amiridis, S., Kountouri, N., Ng, W., Morokoff, A. P., & Mantamadiotis, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172791 · Cited by 172
Wei, W., Shin, Y. S., Xue, M., Matsutani, T., Masui, K., Yang, H., Ikegami, S., Gu, Y., Herrmann, K., Johnson, D., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.012 · Cited by 168
Pine, A. R., Cirigliano, S. M., Nicholson, J. G., Hu, Y., Linkous, A., Miyaguchi, K., Edwards, L., Singhania, R., Schwartz, T. H., Ramakrishna, R., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0057 · Cited by 168
Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation
Berezovsky, A. D., Poisson, L. M., Cherba, D., Webb, C. P., Transou, A. D., Lemke, N. W., Hong, X., Hasselbach, L. A., Irtenkauf, S. M., Mikkelsen, T., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.03.006 · Cited by 166
Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy
Yan, K., Wu, Q., Yan, D. H., Lee, C. H., Rahim, N., Tritschler, I., DeVecchio, J., Kalady, M. F., Hjelmeland, A. B., & Rich, J. N. (2014) · Genes & Development · doi:10.1101/gad.235515.113 · Cited by 165
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
Jung, E., Osswald, M., Ratliff, M., Dogan, H., Xie, R., Weil, S., Hoffmann, D. C., Kurz, F. T., Kessler, T., Heiland, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21117-3 · Cited by 164
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in glioblastoma
Castellan, M., Guarnieri, A., Fujimura, A., Zanconato, F., Battilana, G., Panciera, T., Sladitschek, H. L., Contessotto, P., Citron, A., Grilli, A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00150-z · Cited by 163
MET Signaling Regulates Glioblastoma Stem Cells
Joo, K. M., Jin, J., Kim, E., Ho Kim, K., Kim, Y., Gu Kang, B., Kang, Y.-J., Lathia, J. D., Ho Cheong, K., Song, P. H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3760 · Cited by 160
Golebiewska, A., Hau, A.-C., Oudin, A., Stieber, D., Yabo, Y. A., Baus, V., Barthelemy, V., Klein, E., Bougnaud, S., Keunen, O., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02226-7 · Cited by 159
Self-citationWenger, A., Vega, S. F., Kling, T., Bontell, T. O., Jakola, A. S., & Carén, H. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz011 · Cited by 158
Nicotinamide metabolism regulates glioblastoma stem cell maintenance
Jung, J., Kim, L. J. Y., Wang, X., Wu, Q., Sanvoranart, T., Hubert, C. G., Prager, B. C., Wallace, L. C., Jin, X., Mack, S. C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90019 · Cited by 150
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
Fack, F., Espedal, H., Keunen, O., Golebiewska, A., Obad, N., Harter, P. N., Mittelbronn, M. G. A., Bähr, O., Weyerbrock, A., Stuhr, L. E. B., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1352-5 · Cited by 148
Self-citationSelf-Renewal Does Not Predict Tumor Growth Potential in Mouse Models of High-Grade Glioma
Barrett, L. E., Granot, Z., Coker, C., Iavarone, A., Hambardzumyan, D., Holland, E. C., Nam, H.-S., & Benezra, R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.025 · Cited by 145
Stieber, D., Golebiewska, A., Evers, L., Lenkiewicz, E., Brons, N. H. C., Nicot, N., Oudin, A., Bougnaud, S., Hertel, F., Bjerkvig, R., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1196-4 · Cited by 126
Self-citationGuilhamon, P., Chesnelong, C., Kushida, M. M., Nikolić, A., Singhal, D., MacLeod, G. D. A. H., Tonekaboni, S. A. M., Cavalli, F. M. G., Arlidge, C., Rajakulendran, N., et al. (2021) · eLife · doi:10.7554/elife.64090 · Cited by 125
Broadley, K. W. R., Hunn, M. K., Farrand, K. J., Price, K. M., Grasso, C., Miller, R. J., Hermans, I. F., & McConnell, M. J. (2010) · Stem Cells · doi:10.1002/stem.582 · Cited by 124
Shen, S., Faouzi, S., Bastide, A., Martineau, S., Malka-Mahieu, H., Fu, Y., Sun, X., Mateus, C., Routier, É., Roy, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13360-6 · Cited by 124
López-Bertoni, H., Lal, B., Li, A., Caplan, M. J., Guerrero‐Cazares, H., Eberhart, C. G., Quiñones-Hinojosa, A., Glas, M., Scheffler, B., Laterra, J., et al. (2014) · Oncogene · doi:10.1038/onc.2014.334 · Cited by 117
Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A
Abdul Rahim, S. A., Dirkse, A., Oudin, A., Schuster, A., Bohler, J., Barthelemy, V., Muller, A., Vallar, L., Janji, B., Golebiewska, A., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.263 · Cited by 111
Self-citationCell Lineage-Based Stratification for Glioblastoma
Wang, Z., Sun, D., Chen, Y.-J., Xie, X., Shi, Y., Tabar, V. S., Brennan, C., Bale, T., Jayewickreme, C. D., Laks, D. R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.003 · Cited by 111
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
Klein, E., Hau, A., Oudin, A., Golebiewska, A., & Niclou, S. P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.604121 · Cited by 111
Self-citationEyler, C. E., Matsunaga, H., Hovestadt, V., Vantine, S. J., van Galen, P., & Bernstein, B. (2020) · Genome biology · doi:10.1186/s13059-020-02085-1 · Cited by 110
Sa, J. K., Chang, N., Lee, H. W., Cho, H. J., Ceccarelli, M., Cerulo, L., Yin, J., Kim, S. S., Caruso, F. P., Lee, M., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02140-x · Cited by 109
GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile
Rusu, P., Shao, C., Neuerburg, A., Acikgöz, A. A., Wu, Y., Zou, P., Phapale, P., Shankar, T. S., Döring, K., Dettling, S., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.06.004 · Cited by 108
Campos, B., Centner, F.-S., Bermejo, J. L., Ali, R., Dorsch, K., Wan, F., Felsberg, J., Ahmadi, R., Grabe, N., Reifenberger, G., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.051 · Cited by 104
BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma
Sachdeva, R., Wu, M., Johnson, K. C., Kim, H., Celebre, A., Shahzad, U., Graham, M. S., Kessler, J. A., Chuang, J. H., Karamchandani, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51270-1 · Cited by 102
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Wu, Y., Fletcher, M., Gu, Z., Wang, Q., Costa, B., Bertoni, A., Man, K.-H., Schlotter, M., Felsberg, J., Mangei, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20225-w · Cited by 101
Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
Golebiewska, A., Bougnaud, S., Stieber, D., Brons, N. H. C., Vallar, L., Hertel, F., Klink, B., Schröck, E., Bjerkvig, R., & Niclou, S. P. (2013) · Brain · doi:10.1093/brain/awt025 · Cited by 95
Self-citationMitchell, K., Troike, K. M., Silver, D. J., & Lathia, J. D. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa259 · Cited by 95
Evolutionary dynamics of residual disease in human glioblastoma
Spiteri, I., Caravagna, G., Cresswell, G. D., Vatsiou, A. I., Nichol, D., Acar, A., Ermini, L., Chkhaidze, K., Werner, B., Mair, R. J., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy506 · Cited by 94
New Opportunities and Challenges to Defeat Cancer Stem Cells
Ramos, E. K., Hoffmann, A. D., Gerson, S. L., & Liu, H. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.08.007 · Cited by 89
Reinartz, R., Wang, S., Kebir, S., Silver, D. J., Wieland, A., Zheng, T., Kupper, M. D., Rauschenbach, L., Fimmers, R., Shepherd, T. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2089 · Cited by 80
Epigenetic Landscaping During hESC Differentiation to Neural Cells
Golebiewska, A., Atkinson, S. P., Lako, M., & Armstrong, L. (2009) · Stem Cells · doi:10.1002/stem.59 · Cited by 79
Self-citationPark, N. I., Guilhamon, P., Desai, K., McAdam, R. F., Langille, E. R., O’Connor, M., Lan, X., Whetstone, H., Coutinho, F. J., Vanner, R. J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.08.008 · Cited by 74
Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma
Pires‐Afonso, Y., Niclou, S. P., & Michelucci, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030689 · Cited by 67
Self-citationReconciling Non-Genetic Plasticity with Somatic Evolution in Cancer
Huang, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.007 · Cited by 67
Chandra, A., Jahangiri, A., Chen, W., Nguyen, A. T., Yagnik, G., Pereira, M. P., Jain, S., Garcia, J. H., Shah, S. S., Wadhwa, H., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1305 · Cited by 64
Nabilsi, N. H., Deleyrolle, L. P., Darst, R. P., Riva, A., Reynolds, B. A., & Kladde, M. P. (2013) · Genome Research · doi:10.1101/gr.161737.113 · Cited by 62
Long non-coding RNAs in cancer stem cells
Schwerdtfeger, M., Desiderio, V., Kobold, S., Regad, T., Zappavigna, S., & Caraglia, M. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101134 · Cited by 62
Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells
Hall, A. W., Battenhouse, A. M., Shivram, H., Morris, A. R., Cowperthwaite, M. C., Shpak, M., & Iyer, V. R. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1724 · Cited by 59
Cancer stem cells and angiogenesis
Bjerkvig, R., Johansson, M., Miletić, H., & Niclou, S. P. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.09.001 · Cited by 56
Self-citationTumor cell network integration in glioma represents a stemness feature
Xie, R., Keßler, T., Grosch, J. K., Hai, L., Venkataramani, V., Huang, L., Hoffmann, D. C., Solecki, G. M., Ratliff, M., Schlesner, M., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa275 · Cited by 53
Berg, T. J., Marques, C., Pantazopoulou, V., Johansson, E., von Stedingk, K., Lindgren, D., Jeannot, P., Pietras, E. J., Bergström, T., Swartling, F. J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1785 · Cited by 52
Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition
Serresi, M., Kertalli, S., Li, L., Schmitt, M. J., Dramaretska, Y., Wierikx, J., Hulsman, D., & Gargiulo, G. (2021) · Science Advances · doi:10.1126/sciadv.abd7974 · Cited by 52
Fouse, S. D., Nakamura, J. L., James, C. D., Chang, S. M., & Costello, J. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not223 · Cited by 41
Oudin, A., Baus, V., Barthelemy, V., Fabian, C., Klein, E., Dieterle, M., Wantz, M., Hau, A., Dording, C., Bernard, A., et al. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100534 · Cited by 37
Self-citationA non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR
Al-Mayhani, T. M. F., Heywood, R. M., Vemireddy, V., Lathia, J. D., Piccirillo, S. G. M., & Watts, C. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy204 · Cited by 20
Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells
de la Rocha, A. A., López-Bertoni, H., Guruceaga, E., González-Huarriz, M., Martínez-Vélez, N., Xipell, E., Fueyo-Margareto, J., Gomez‐Manzano, C., & Alonso, M. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163155 · Cited by 17
Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma
Fritah, S., Muller, A., Jiang, W., Mitra, R., Sarmini, M., Dieterle, M., Golebiewska, A., Ye, T., Dyck, E. V., Herold‐Mende, C. C., et al. (2020) · Cancers · doi:10.3390/cancers12092583 · Cited by 14
Self-citation
Cited by
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Liu, Y., Zhou, F., Ali, H., Lathia, J. D., & Chen, P. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01226-x · Cited by 336
Metadata
- Authors
- Yabo, Y. A., Niclou, S. P., & Golebiewska, A.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-12-21
- Volume
- 24
- Issue
- 5
- Pages
- 669-682
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W4200347391
- Cited by
- 306
- References
- 155
- FWCI
- 19.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.